Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

The Oncology Institute Inc (TOI)

The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 378,767
  • Shares Outstanding, K 98,381
  • Annual Sales, $ 393,410 K
  • Annual Income, $ -64,660 K
  • EBIT $ -34 M
  • EBITDA $ -22 M
  • 60-Month Beta 0.15
  • Price/Sales 0.72
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 90.84% (-13.00%)
  • Historical Volatility 69.91%
  • IV Percentile 10%
  • IV Rank 3.09%
  • IV High 504.75% on 07/24/25
  • IV Low 77.63% on 08/15/25
  • Expected Move (DTE 3) 0.21 (5.52%)
  • Put/Call Vol Ratio 0.66
  • Today's Volume 209
  • Volume Avg (30-Day) 408
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 58,274
  • Open Int (30-Day) 57,705
  • Expected Range 3.64 to 4.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.10
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.22 +19.38%
on 12/22/25
4.49 -14.16%
on 01/09/26
+0.07 (+1.85%)
since 12/12/25
3-Month
2.88 +33.68%
on 11/25/25
4.88 -21.11%
on 10/24/25
+0.06 (+1.58%)
since 10/10/25
52-Week
0.27 +1,315.44%
on 01/13/25
4.88 -21.11%
on 10/24/25
+3.55 (+1,176.10%)
since 01/10/25

Most Recent Stories

More News
The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook

CERRITOS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, today...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)
The Oncology Institute Announces Leadership Promotions

Rakesh Panda appointed Chief Information Officer Nolan Mariano appointed Chief People Officer CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI)...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The war on cancer is moving into a high-tech era of molecular-guided defense. The genomics in cancer care...

ONCY : 0.9916 (+2.47%)
PYXS : 2.06 (+17.05%)
PSNL : 8.57 (+5.80%)
NBP : 3.72 (+0.54%)
TOI : 3.85 (-7.89%)
The Oncology Institute Announces Addition of Board Member Mark Stolper

CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Mark...

TOIIW : 0.1534 (-5.60%)
RDNT : 76.35 (-2.37%)
TOI : 3.85 (-7.89%)
The Oncology Institute Announces Resignation of Board Member Gabe Ling

CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)
Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration

CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ascertain , a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institute,...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call

CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI),  a pioneer in value-based community oncology care, today announced that the company will release...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)
BTIG Sticks to Their Buy Rating for Oncology Institute (TOI)

BTIG analyst David Larsen reiterated a Buy rating on Oncology Institute today and set a price target of $7.00. The company’s shares closed yesterday at $3.48.Elevate Your Investing Strategy: Take advantage...

TOI : 3.85 (-7.89%)
The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference

CERRITOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that  Dr. Daniel Virnich, Chief Executive...

TOIIW : 0.1534 (-5.60%)
TOI : 3.85 (-7.89%)

Business Summary

The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 4.55
2nd Resistance Point 4.40
1st Resistance Point 4.13
Last Price 3.85
1st Support Level 3.70
2nd Support Level 3.55
3rd Support Level 3.28

See More

52-Week High 4.88
Last Price 3.85
Fibonacci 61.8% 3.12
Fibonacci 50% 2.58
Fibonacci 38.2% 2.03
52-Week Low 0.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar